NRAS and Splenomegaly: Clinically, CBL mutations were associated with a more proliferative phenotype evidenced by increased bone marrow blasts, leukocytosis and splenomegaly, similar to other RAS pathway mutations such as KRAS, NRAS and PTPN11.